Purpose Detection of antinuclear antibodies has traditionally been performed by immunofluorescence (IFA) on fixed culture cells or tissues with reactivity being reported as a fluorescence pattern associated to one or more nuclear antigens. For this study, we compared results from IFA testing with a multiplex antinuclear antibody assay on a panel of patient serum samples previously evaluated by ...

The clinical presentation of scleroderma in childhood is even more varied than in adult life. This study of 19 children shows that antinuclear antibodies (ANA) detected on the HEp2 cell substrate are just as common as in the adult disorders. All seven children with diffuse scleroderma or acrosclerosis were ANA positive, as were eight of the 12 with more localised disease. Antinucleolar antibodi...

OBJECTIVES To evaluate in patients with multiple sclerosis (MS) the occurrence of clinical systemic signs and biological autoimmune abnormalities, including positive titers of antinuclear antibodies and antiphospholipid antibodies, suggestive of autoimmune diseases that may affect the central nervous system. Also, to compare the clinical and magnetic resonance imaging features and evolution of ...

AND PRINCIPLES Autoimmune disorders can be Non-organ Specific, Tissue or Organ Specific or Overlapping assiciated with both organ specific and non organ specific antibodies. The five most common autoimmune antibodies include: 1. Antinuclear antibodies (ANA) 2. Antimitochondrial antibody (MA) 3. Antismooth muscle antibodies (SMA) 4. Antiparietal cell antibodies (PCA) 5. Antireticulin antibody (RA)

This is a review and update article on antinuclear antibodies assays, in particular the antinuclear factor, in which are approached histological and epidemiological aspects, physiopathogenesis, identification methods, their specificities and interpretation, correlating them to their applicability in the dermatologist's and general clinician's clinical practice.

Autoantibodies to the three extractable nuclear antigens (ENA), Anti-SSA (Ro), Anti-Sm, Anti-RNP and antinuclear antibodies were determined in 150 patients with SLE. Seventy patients (46.7%) had Anti-SSA (Ro), 40 (26.7%) Anti-Sm and 25 (16.7%) Anti-RNP antibodies. Ninety four percent patients had a positive Fluorescent anti-nuclear antibody (FANA) test. The commonest FANA pattern is the speckle...